9Manam S, Ledwith B J, Barnum A B, et al. Plasmid DNA vaccines: tissue distribution and effects of DNA sequence adjuvant and delivery method on integration into host DNA [J]. Intervirology, 2000, 43:273 -281.
10Moormann M, de Rover T, Briaire J, et al. Inactivation of the thymidine kinase gene of a g1 deletion mutant of Pseudorabies virus generate a safe but still highly immunogenic vaccine strain[J]. J Gen Virol, 1990, 71:1591- 1595.
5Schwartz J A,Brittle E E,Reynolds A E,et al. UL54-null pseudorabies virus is attenuated in mice but productively infects cells in culture[J]. J Virol, 2006,80 (2) : 769-784.
6Delrio T,Decoste C J,Enquist L W. Actin is a component of the compensation mechanism in pseudorabies virus virions lacking the major tegument protein VP22 [J]. J Virol, 2005,79 (13) 8614-8619.
7Fuchs W,Granzow H,Klupp B G,et al. Relevance of the interaction between alphaherpesvirus UL3.5 and UL48 proteins for virion maturation and neuroinvasion[J]. J Virol, 2007,81 (17) : 9307-9318.
8Leege T, Granzow H, Fuchs W, et al. Phenotypie similarities and differences between UL37-deleted pseudorabies virus and herpes simplex virus type 1[J]. J Gen Virol,2009,90(7) :1560- 1568.
9Leege T,Fuchs W, Granzow H, et al. Effects of simultaneous deletion of pULll and glycoprotein M on virion maturation of herpes simplex virus type 1 [J]. J Virol, 2009,83 (2) : 896-907.
10Coller K E,Smith G A. Two viral kinases are required for sustained long distance axon transport of a neuroinvasive herpesvirus[J]. Traffic,2008,9(9), 1458-1470.
